Although the role of adiposity in survival is still under debate, a recent meta-analysis showed that obesity, when assessed by BMI, was associated with modestly worse disease-free survival and overall survival in all breast cancer subtypes (HR+HER2−, HER2+, and triple negative) [23]. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.